UPL
UPL Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
UPL expects total cropland in the next 12 months to be equal or larger than the previous 12 months, supporting stable or growing demand for crop protection products. Q1 FY27 guidance: Revenue growth of 10%-14%, EBITDA growth of 14%-18%, reflecting cautious optimism amidst macro uncertainties (Page 24, 23).
From UPL's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- UPL expects total cropland in the next 12 months to be equal or larger than the previous 12 months, supporting stable or growing demand for crop protection products.
- Volume growth is anticipated across key segments: India SAS business, Advanta, and SUPERFORM specialty business, with UPL Corp volumes expected stable in Q1.
- New product launches are key to growth, with over 100 products planned in FY27 generating around $115 million in new revenue.
- Specialty chemicals segment SUPERFORM aims for 20%+ annual growth, outpacing industry peers, driven by vertical integration, new product launches, and AI adoption.
- Organic growth focus with market share gain in core markets through strengthened customer relationships and operational excellence.
- Innovation and differentiated products expected to drive margin expansion and resilient growth amid volatile pricing.
2 more points management made on revenue & sales performance
Profitability & Margins
See what UPL said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- UPL plans to slightly increase capex for the upcoming year to around $300 million to $350 million (likely around $325 million), up from $261 million in the prior year.
- Increased investment will focus on specialty chemicals due to significant opportunities and long-term contracts with global players seeking to source UPL capacity.
- There is also emphasis on backward integration projects aimed at enhancing margin profiles and building additional EBITDA.
- Capital expenditure remains disciplined, with past capex in the range of $225 million to $250 million.
2 more points management made on capital expenditure plans
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what UPL said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- UPL does not take advanced orders as they did 2-3 years ago; distribution now buys closer to the season.
- Farmers in Brazil prepare for soybean planting in September-October; channel negotiations for deliveries occur in July-August.
- Q1 in Brazil represents a small in-season business; Q2 is the main stocking period for the upcoming season.
2 more points management made on order book & pipeline
UPL — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹18.3K Cr, net profit ₹1.3K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What UPL's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
- Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Indogulf Cropsci (Q4 FY26)
Successful single order in Venezuela contributing approximately INR 4 crores in revenue, indicating active export orders. Key concall takeaways from Indogulf…
- Rallis India Ltd (Q4 FY26)
Crop Protection B2C business growth excluding Soil & Plant Health (SPH) will be marginally positive to low single digit; SPH segment grew robustly at 27%. Key…
Frequently Asked Questions
What were UPL Q4 FY26 results?
UPL expects total cropland in the next 12 months to be equal or larger than the previous 12 months, supporting stable or growing demand for crop protection products. Q1 FY27 guidance: Revenue growth of 10%-14%, EBITDA growth of 14%-18%, reflecting cautious optimism amidst macro uncertainties (Page 24, 23).
What is UPL share price analysis?
UPL currently shows a neutral. The stock trades at a P/E of 24.8 with a market cap of ₹48,946 Cr. Investors should review the full earnings analysis for detailed insights.
Is UPL planning capital expenditure?
UPL plans to slightly increase capex for the upcoming year to around $300 million to $350 million (likely around $325 million), up from $261 million in the prior year.
Keep UPL on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.